The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients

• Moo Hyun Lee,

  Affiliation Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea

  ⨯
• So-Youn Jung,

  Affiliation Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea

  ⨯
• Sun Hee Kang,

  Affiliation Department of Surgery, Keimyung University, School of Medicine, Daegu, Republic of Korea

  ⨯
• Eun Jin Song,

  Affiliation Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea

  ⨯
• In Hae Park,

  Affiliation Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea

  ⨯
• Sun-Young Kong,

  Affiliation Department of Laboratory Medicine, Center for Diagnostic Oncology, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea

  ⨯
• Young Mee Kwon,

  Affiliation Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea

  ⨯
• Keun Seok Lee,

  Affiliation Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea

  ⨯
• Han-Sung Kang,

  Affiliation Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea

  ⨯
• Eun Sook Lee

  * E-mail: eslee@ncc.re.kr

  Affiliation Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea

  ⨯